Transcript Document

EFFICACY OF CEM-THERAPY
Selection of publications for the clinical test review
The publications, describing the terminated prospective
controlled tests of the EHF-therapy (extreme high frequency) at
the different diseases, in which the patient groups were selected
by the randomization or minimization methods and compared
according to the age, sex, gravity and duration of disease, a
presence of attendant diseases and the investigation results
were adequately statistically treated, are included into review.
The clinical investigations, made on more than 8000 patients
and healthy volunteers in the large medical centers of Moscow,
Tomsk, Saratov, Nizhny Novgorod and etc., were meeting the
selection criteria.
Treatment
The EHF-therapy effectiveness in the modes analogous
to the CEM-TECH apparatus modes was assessed
(noise, BRR-background resonance radiation). The
EHF-therapy was isolated or at the background of a
standard therapy compared to a standard therapy. The
EHF-range EMR (electromagnetic radiation) effected the
affected organ projections or a pathologic focus and/or
the biologically active points (BAP) and zones. There
was no the EHF-therapy in the control groups or there
was the EHF-effect imitation, i.e. a blind placebo control.
Spine pain syndrome
percent of
recovered
group 1 is control, group 2 recieved EHF
therapy
60,00
p<0,05
40,00
20,00
0,00
1
2
groups
Totally, 407 patients at the age of 19-83 years with the vertebral
osteochondrosis neurologic manifestations were examined and treated.
Thus, an expressed anesthetic effect of the EHF-therapy at the vertebral
osteochondrosis neurologic manifestations is established.
Cerebrovascular pathology
percent of
recovered
group 1 is control, group 2 recieved EHF
therapy
80,00
60,00
40,00
20,00
0,00
p<0,05
1
2
groups
A headache, vertigo, the arterial pressure (AP) fluctuation were abruptly eased after
the EHF session in the basic group patients with an asthenic disorder. The AP was
stabilized in more than 75% of patients on the 5-6 procedure (in a control group – on
the 10-12 day), a headache was less intensive rapidly disappearing. The asthenic
manifestations were smoothly vanishing.
Trigeminal neuralgia
percent of
recovered
group 1 is control, group 2 recieved EHF
therapy
80,00
60,00
40,00
20,00
0,00
p<0,01
1
2
groups
Megdiatov et al. were reporting of the EHF effective use in patients with the
trigeminal neuralgia. A reduced pain intensity and a decreased incidence of the
neuralgia attacks were noted in 19 of 27 patients from a group 2 (an actual EHF)
compared to 4 of 25 patients from a control group, receiving a sham EHF
procedure.
Syndrome of vegetative dystonia
percent of
recovered
group 1 is control, group 2 recieved EHF
therapy
100,00
50,00
p<0,0001
0,00
1
2
groups
503 patients at the age of 5-63 years with a vegetative dystonia syndrome were
examined and treated. Since the 3-4 day of treatment the fatigability, irritability,
emotional liability, a sleep disturbance, headaches have been decreasing or
disappearing at the EHF-therapy use. A working capacity and mood have been
increasing.
Traumatic and postoperative pain
syndrome
percent of
recovered
group 1 is control, group 2 recieved EHF
therapy
100,00
p<0,05
50,00
0,00
1
2
All investigators have noted an expressed anesthetic effect of the EHF-therapy. The
pain decrease in a postoperative wound was ingroups
3-12 hours after the first session, a full
disappearance of pains was beginning in the proximate 2 days. The EHF-therapy use
was leading to a promedol dose three times decrease for the postoperative pain
cupping. The pains in wound have been aching for 3-5 days in the control group
patients.
Joint diseases
percent of
recovered
group 1 is control, group 2 recieved EHF
therapy
100,00
p<0,05
50,00
0,00
1
2
groups
Totally, 500 patients at the age of 25-79 years with the degenerative and dystrophic
diseases of joints were examined and treated.
arthritis
Before
therapy
After CEM-Tech
device therapy
Stomach and duodenal ulcer
percent of
recovered
group 1 is control, group 2 recieved EHF
therapy
100,00
p<0,001
50,00
0,00
1
2
groups
Totally, 913 patients with an ulcerous disease of the stomach and duodenum were
examined and treated.
The ulcerous defect epithelization dates were assessed. An inclusion of the EHFtherapy into a medical complex leads to the epithelization date reduction by 2-4
days, in the average (14-16 days versus 18-20 days in a control group).
Psoriasis
percent of
recovered
group 1 is control, group 2 recieved EHF
therapy
100,00
p<0,05
50,00
0,00
1
2
groups
Totally, 336 patients at the age of 14-72 years with psoriasis were examined and
treated (the extended psoriasis – in 76 humans, a psoriatic arthritis – in 58
humans).
All investigators were noting the anti-inflammatory, analgetic, regenerative effect,
a resorption of infiltrates at the EHF-therapy inclusion into a medical complex.
Ischemic heart disease –
antianginal effect
percent of
recovered
group 1 is control, group 2 recieved EHF
therapy
100,00
p<0,001
50,00
0,00
1
2
groups
Totally, 616 patients at the age of 41-69 years with the ischemic heart disease
(IHD) were examined and treated.
The EHF-therapy in acute period in patients
with a myocardial infarction
Good clinical effect
Satisfactory clinical effect
100,00
50,00
group 1 is control, group 2 recieved EHF
therapy
percent of
recovered
percent of
recovered
group 1 is control, group 2 recieved EHF
therapy
p<0,01
0,00
1
2
groups
100,00
50,00
p<0,05
0,00
1
2
groups
Prostatitis
Leucocytes content in PG
Expressivity of pain syndrome (%)
80
30
before treatment
70
after treatment
in the visual field
40
30
20
10
after treatment
25
60
50
before treatment
20
15
10
5
0
1
2
Figure 1
control
0
1
2
control
Figure 2
Thereby, high effectiveness of EHF-therapy in bioresonance
regime during chronic prostatitis was shown. EHF-therapy has expressed
anesthetic action, it eliminates inflammatory occurrences, improves
functional activity of prostate gland, leads to correction of immunologic
disturbances and sexual function stimulation.
Intestine cancer – wound healing
percent of
recovered
group 1 is control, group 2 recieved EHF
therapy
100,00
p<0,01
50,00
0,00
1
2
groups
Modern indications to the EHF-therapy use in
oncology in the following form:
 Preparation of patients with the basic localization cancer to the
combined treatment stages (preparation of the organs and systems to
a surgical trauma, radial damages and a medicinal aggression).
 Treatment of the attendant diseases and a prophylaxis of
complications in humans from the risk groups.
 Prophylaxis and elimination of complications after the special
methods of treatment.
 Treatment of a paraneoplastic syndrome.
 Increase of the other treatment method results.
 Symptomatic therapy of the incurable patients.
 Systemic correlation of the ecologic and precancerous pathology.
 Prophylaxis of a tumor process progress after a combined treatment.
Analysis of the publications about clinical
tests let us make conclusions that EHF
influence on the organism allow to:
reduce pain of any genesis and inflammations in
pathologic spots;
reduce rehabilitation treatment period of the wide
spectrum of diseases;
increase the potential of rehabilitation treatment in the
outpatient and home setting;
perform primary and secondary prophylactics;
rise the efficiency of medicaments use, and at the same
time low the dose of prescribed medicine, and in some
cases refuse from medicaments appliance.
All scientific efforts confirmed good tolerance of
human body to EHF influence, and the absence
of complications and side effects. The same can
be applied to long-term observation of recovering
patients (1-2 years), the absence or insignificant
perception in the point of influence was observed
(some patients had a perception of “light tingling”
and “goose skin”).
There are no any revealed serious
contraindications for its use, however one
should avoid its prescription in the following
cases:
unstated diagnose;
individual intolerance of this type of therapy
pregnancy
driving and other work connected with danger and
concentration (management of mechanisms and so forth).
In the table below there are nosologic forms and
registered basic effects of EHF-therapy;
cardio stimulator.
In the following table you can see
nosologic forms and the main
registered effects of EHF
therapy:
Neuropathology
1. Naturopathic manifestations of
spine osteochondrosis,
including discogenic
radiculopathy
Evident anesthetic effect, increase in pain
threshold in local alogenic zones
2. Spine silicosis in children
Evident anesthetic effect, increase in
tolerance to physical activity, increase in
spine excursion
3. Vertebrobazilare deficiency
Disappearance or substantial decrease in
headache and vertigo, blood pressure
normalization
4. Brain exogeno-organic
affections (traumatic,
vascular, infectious-toxic
and complex genesis)
Disappearance of asthenic manifestations,
emotional instability, hypertension,
headache, vertigo, blood pressure
fluctuation, night sleep restoration
Neuropathology
5. Cerebral atherosclerosis
Cerebral blood flow normalization, lipidic
metabolism indicators normalization
6. Headache
Significant decrease of intensity of
headache and duration of attacks
7. Mono- and poly-neuropathy
Analgetic effect, the speed increase of
impulse conduction on nerves
8. Vegetative distony syndrome,
including vegetative crisis (panic
attack)
Vegetative status normalization, decrease
or disappearance of headaches,
improvement of geodynamics on the basis
of rheography data
9. Reactive neurosis and stress
reactions – treatment and
prevention
Decrease or disappearance of irritability,
emotional instability, sleep disturbances,
increase in efficiency, mood increase
10. Cerebral spastic infantile
paralysis
Decrease in muscular tone, increase in the
range of active motions
Joint diseases
11. Degenerative dystrophic joint
diseases (deforming osteoarthritis,
Perthers’ disease, psoriatic
osteoarthropathy)
Anti-inflammatory effect, increase in
muscle strength, range of motions in
interested joint and tolerance to physical
activity
12. Hemarthrosis and hemophilic
artropathy
Analgetic effect, hemostasis normalization
13.Atrophic arthritis
Significant decrease in pain and morning
joint stiffness, immunomodulatory effect
Surgical pathology
14. Traumatic and postsurgical
skin injuries of bone and soft
tissues, including complicated
with suppurative inflammation
and sluggish wounds
Shortening of all phases of wound process,
anti-inflammatory action, regeneration
stimulation, suppuration prophylactics,
evident analgetic effect, decrease in the
dose of analgetic medications
15. Burns
Analgetic effect, fast formation of
granulation tissue and epithelization
16. Posttraumatic osteomyelitis
Shortening of inflammation exudative
phase period and stimulation of the earlier
start of reparative processes, normalization
of cytomorphologic leukocyte
characteristics
Surgical pathology
17. Posttraumatic stiffness
Analgetic effect, normalization of
microcirculation and trophic disturbances,
restoration of normal range of motions
18. Acute cholecystitis
Anti-inflammatory action
19. Acute pancreatitis
Shortening of the treatment period, positive
influence on the condition of immune
system
Gastroenterology
20. Gastric ulcer and duodenal
ulcer disease, including
complicated with bleeding and
perforation or penetration
Shortening of epithelization period of ulcer
effect , decrease in the amount of
recurrences
21. Incompetence of bileexcreting tracts
Faster and more effective pain and
dyspepsia syndromes reduction, decrease
in signs of thickening and crystallization of
bile, normalization of gallbladder contractile
function
22. Chronic gastroduodenitis,
including the one with presence
of Helicobacter pilori infection
Faster and more effective pain and
dyspepsia syndromes reduction
23. Chronic pancreatitis
Effective pain reduction, restoration of
pancreas functions
Obstetrics and gynecology
25. Chronic adnexitis, including
cases with reproductive function
disorder
anesthetic effect, commissural structures
softening, restoration of reproductive
function
26. Miscarriage of pregnancy
Growth of luteal phase term of menstrual
cycle, rise of oestradiol and progesterone
levels, cancel of need in hormonotherapy
27. Postabortal complications
immunomodeling effect, reduction of
inflammatory complications
Dermatology
25. Psoriasis
Anti-inflammatory, analgetic, regenerative
effect, infiltrate resorption, shortening of
treatment period, decrease in the number
of recurrences
26. Trophic ulcer
Anti-inflammatory, analgetic, regenerative
effect, infiltrate resorption, shortening of
treatment period, epithelization of ulcer
defects
27. Atopic dermatitis
Anti-allergenic effect, itch termination
28. Microbial eczema
Faster recovery
29. Acne
Faster recovery
30. Neurodermatitis
Skin itch decrease
Infectious and Parasitic diseases
31. Chronic opisthorchiasis
Improvement of contractile function
characteristics and gallbladder volume
characteristics, disappearance of opisthorhid
eggs in bile
32. Pulmonary tuberculosis, including
chlamidia and mycoplasmal infections
Stabilization during pulmonary tuberculosis,
decrease in occurrence of postsurgical
complications
33. Tick-borne encephalitis and tickborreliosis
Motion activity increase, decrease in intensity of
headaches and arthralgia, sleep normalization,
decrease in fever period, weakness and
sweating, increase of antibody titer to antigens
of tick-borne encephalitis and tick-borreliosis
34. Viral hepatitis
35. Acute respiratory virus infections –
prevention and treatment
Faster recovery
Morbidity reduction in 2 times, disease behavior
in a lighter form, decrease in the morbidity
period, absence of complications of acute
respiratory virus infections
Cardiology
36. Ischemic heart disease: exertional
angina, instable angina, myocardial
infarction, arrhythmia
Evident antianginal effect, decrease in the
number of episodes of painless myocardial
ischemia, improvement of diastolic function of
left ventricle, decrease in the number of
stenocardia attacks, decrease of arrhythmia
episodes, decrease in the dose of nitroglycerin,
normalization of activity level of antithrombin III
and erythrocyte deformability
37. Alternative hypertension, including
hypertonic crisises
Hypertensive effect, decrease in resistance of
peripheric vessels, improvement of arterial brain
circulation indicators, decrease or
disappearance of passive congestion signs,
catecholamines excretion normalization
38. Noncoronary myocardial traumas
(mitral valve prolapse,
cardiomyopathy, myocarditis)
reduction of cardialgia episodes, improvement of
life quality, normalization of hemostasis system
indexes
Pulmonology
38. Pneumonia
Effectiveness increase and shortening of
treatment periods, prevention of lingering illness
process
39. Bronchial asthma
Decrease in cough and dyspnea, decrease in
the need of inhalation bronchial spasmolytic,
improvement in bronchial secretion discharge,
decrease in the number of rales, external
respiration function normalization,
immunomodulative effect
40. Chronic neobstructive bronchitis
Anti-inflammatory effect
41. Chronic obstructive bronchitis
Reduction of bronchoobstruction syndrome
42. Lung and intrachest lymph nodes
sarcoidosis
Normalization of roentgenogram indexes,
immunograms and outer breath function,
reduction of acerbations and relapses frequency
Stomatology
42. Adentia and dental
prosthesis application
Evident anti-inflammatory effect
43. Paradontitis
Evident anti-inflammatory effect,
regeneration stimulation, local blood
circulation normalization in paradonta
44. Gingivitis
Evident anti-inflammatory effect
Oncology
45. Malignant neoplasms (cancer of
large and rectum intestine, skin
melanoma, stomach cancer,
mammary tumor, lung cancer, ovarian
cancer, and others)
Decrease in the number and intensity of
polychemotherapy complications, decrease in
the number of recurrences and metastases, pain
relief effect
46. Benign tumors of mammary
glands
Prevention of malignant degeneration, antiinflammatory effect
47. Benign tumors of ovarian
Normalization of secretion of sex hormones and
immune status
48. Uterus fibromyoma
Decease in node size
49. Lymphomas
Activation of organism antioxidative protection,
(lymphogranulomathosis no Hodgkin’s suppression of free radical oxidation and
lymphomas)
normalization of proinflammatory cytokines level
Endocrinology
49. Diffuse toxic goiter
Decrease in the size of thyroid gland,
change in its consistency
50. Nodular goiter
Disappearance or rapid decrease of
solitary noduls
51. Diabetes and its
complications (micro- and
macro- anginophathy,
hepatosis, cataract,
nephropathy, cardiopathy)
Regression of complications, diabetes
course stabilization, decrease in insulin
dosage
Andrology
52. Andropausal disorders
Increase in sexual desire, sexual
function improvement
53. Benign hyperplasia of
prostate gland
Increase in sexual desire, sexual
function improvement
54. Chronic prostatitis
Reduction of pain and dysuric
syndromes, sexual function
improvement
55. Secretio-toxic sterility
Spermatogenesis stimulation
Eye diseases
56. Diabetic retinopathy
Improvement of electrocullogram
indicators, disappearance of
unpleasant feeling in the eye
57. Eye inflammation diseases, Itch termination, anti-allergenic effect
including allergenic genesis
58. Degenerative retina and
visual nerve diseases
Rise of visual acuity, visual spreading,
improvement of microcirculation in
bulbar conjunctive
Liver diseases
58. Cirrhosis
Normalization of biochemical indicators,
size and structure of liver
59. Chronic hepatitis
Normalization of biochemical indicators,
size and structure of liver
60. Hepatosis
Normalization of biochemical indicators,
size and structure of liver
61. Toxic affection of liver
Normalization of biochemical indicators,
size and structure of liver
Vessel diseases
62. Obliterating atherosclerosis of
arteries of lower limbs
Elimination of pain syndrome, decrease of
intermittent claudication
63. Obliterating endarteritis
Elimination of pain syndrome, decrease of
intermittent claudication
64. Raynaud’s disease
Normalization of peripheral circulation and
microcirculation
65. Post-thrombophlebitic
syndrome
Elimination of pain syndrome, faster
healing of trophic ulcer
Narcology
66. Chronic alcoholism
Decrease in internal stress, anxiety,
alcohol desire
67. Toxicomania
Positive impact on psycho, emotional,
and somatic spheres
Mechanisms of EHF Action
After analyzing information from literary sources,
we can list the following mechanisms of EHF
action on human body:
Normalization of immune system functioning (increased
number of T- and decreased number of B-lymphocytes and
immunoglobulins (Ig) A and M (Bakaliuk et al., 1998),
increased number of T-lymphocytes in comparison with
baseline (Kuz’menko, 1998), the concentration of
circulating immune complexes, B-lymphocytes and
immunoglobulin G decreased and the number of Tlymphocytes and IgA increased (Shliapak et al., 1996), the
decrease of CD8+ positive T-lymphocytes (Jin Z, Lin M, Xia
J, Zhuang J, Yang R, Li X, et al., 2001), normalization of
prior existing disimunnoglobulinea and normalization of
functional activity of neutrophiles (Briskin B.C. and et al,
2003), rehabilitation of functional activity of B-lymphocytes
and phagocytic activity of neutrophiles (Bukatko B.N., 2003)
Increase of nonspecific body resistance
(Tumanyac E.E., Termuryanc N.A., 1997);
Normalization of lipidic metabolism indicators
(increased concentration of high-density
lipoproteins, decrease of triglycerides (Kuz’menko,
1998));
Normalization of pro- and anti-oxidant systems
ratio (Tumanyac E.E., Temuryanc N.A., 1997);
Activation of cell regeneration (increase in
proliferation of fibroblasts (Polyakova A.G. et al.,
1999))
Normalization of the bioelectric brain activity
(stabilization of α-rhythm) and disappearance of
the pathologically slow δ-waves monitored by
means of electroencephalography (Tyshkevich et
al., 1998), increase in spectral facility of
electroencephalogram α-rhyme (Gubarec M.Y.,
1989), and rehabilitation of initially disturbed
interzonal and interhemispheric interrelations of
basic electroencephalogram rhymes (Stolbikov A.
E. and et al, 1991)
Activation of hemopoesis in red bone marrow
(Lebedeva N.N., Kotrovskaya T.I., 2002);
Normalization of rheological blood properties
(lowering of blood viscosity, increase of
erythrocytes deformation (Parshina S.S. and et al,
2003));
Normalization of coagulant and anticoagulative
factors balance (normalization of antithrombin III
level (Lopatina N.A. and et al, 2003),
normalization of fibrinolitic activity and
thrombocyte hemostasis (Bukatko V. N., 2003))
Normalization of vessel tone and microcirculation
activation (normalization of endothelium vessel
reactivity (Parshina S.S. and et al, 2003),
normalization of rheogram indicators (Dikke G.B.,
1999; Afanaseva T.N., Petrova V.D., 1995) and
rheoencephalogramm indicators (Tcarev A.A.,
Kudinova M.A., 1997));
Normalization of vegetative regulation, stabilization
of sympathetic and parasympathetic parts ratio of
vegetative nervous system (Dikke G.B., 1999)
Normalization of kateholomin and sexual hormones
secretion (Tcarev A.A., Kudinova M.A., 1997;
Zaporozhan V.N. et al., 1997);
Influence on endogenous opioid system (Radzievsky
et al., 2001), activation of antinociceptive system
(Kirova B.N., 2000);
Antistress action – suppression of excessive activity of
symphato-adrenal system and activation of stresslimiting systems (Chuyan E.N., Temuryanc N.A., 2005)
Suppression of influenza virus reproduction inside the
cells and viricidic effect (Podchernyaeva R.Y. et al.,
2004);
Rehabilitation of mononuclear ability to secret γinterferon, which enables the decrease in possibility of
cancer development for risk group patients (Sitko S.P.
et al., 1993);
Cytoprotective action towards red marrow cells and
liver during polychemotherapy (Karaeva N.P. et al.,
2006)
Change in structure-dynamic characteristics of cell
membranes (Semina I.G. et al., 2007);
Anti-inflammatory effect, based on stimulation of mast
cell degrannulation and measurement of phagocytes’
functional activity in the center of inflammation
(Gapeev A.B, Chemeris N.K., 2007);
Inhibition of skin, liver, and brain aging processes
(Rodshtat I.V., 2007)
Clinical approbation has shown, that the given
EHF-therapy is especially effective in cases of
medicinal intolerance, presence of contraindications to methods of traditional physio- and
reflexotherapies, as well as insufficient efficiency of
the mentioned ways of treatment. The use of EHFtherapy normalizing psychoemotional and
regulatory processes in organism, allows to
optimize rehabilitation of patients with acute and
chronic diseases of various organs and organ
systems.
It allowed to reject in the given
owner’s manual the usual
description of medical techniques
as «concrete illness – a therapy
technique» using principle of
initial restoration regulatory
processes with subsequent use of
«therapy techniques of organ or
organ system illness».
Possible variants of EHF-therapy use:
pathologic focus
affected organ projections
biologically active points (BAP) and zones
big blood vessels projection
Biologically active zones
Frontal view
Pulmonary abnormalities
Gastritis
Liver disorders
Gallbladder diseases
Fine bowels disorders
Large bowels disorders
Renal abnormalities
Changes in hip joint
Changes in knee joint
Urinary bladder diseases
Stenocardic syndrome
Heart failure
Heart ischemia
Spleen diseases
Pancreas abnormalities
Prostata gland and urinary bladder diseases
Sigmoid colon abnormalities
Sexual disorders
Maldigestion
Diseases in sexual sphere
Visual acuity loss
Stomach diseases
Biologically active zones
Rear view
Cervicalpart of spinal cord
osteochondrosis
Heart abnormalities
Spleen diseases
Gastric ulcer
Pancreas abnormalities
Stomach diseases
Large bowels disorders
Renal abnormalities
Sexual disorders
Changes in hip joint
Ureter abnormalities
Urinary bladder diseases
Gallbladder diseases
Bile duct diseases
Pulmonary abnormalities
Liver disorders
Adrenal gland diseases
Fine bowels disorders
Diseases of organs of small pelvis
All CEM® science news see
www.cem-tech.ru
THANK YOU FOR
ATTENTION!